Page last updated: 2024-08-25

lead and gsk-j4

lead has been researched along with gsk-j4 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brancale, A; Chalmers, IW; Ferla, S; Forde-Thomas, J; Geyer, KK; Hoffmann, KF; Hulme, BJ; Padalino, G; Whatley, KCL; Whiteland, H	1

Other Studies

1 other study(ies) available for lead and gsk-j4

Article	Year
The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets. PLoS neglected tropical diseases, 2019, Volume: 13, Issue:11 Topics: Animals; Anthelmintics; Benzazepines; Computational Biology; Dose-Response Relationship, Drug; Drug Repositioning; Epigenesis, Genetic; Female; Genomics; Hep G2 Cells; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lead; Male; Models, Molecular; Molecular Docking Simulation; Oviposition; Pyrimidines; Schistosoma mansoni; Schistosomatidae; Schistosomiasis; Schistosomiasis mansoni	2019

Article

Year

The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.

PLoS neglected tropical diseases, 2019, Volume: 13, Issue:11

Topics: Animals; Anthelmintics; Benzazepines; Computational Biology; Dose-Response Relationship, Drug; Drug Repositioning; Epigenesis, Genetic; Female; Genomics; Hep G2 Cells; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lead; Male; Models, Molecular; Molecular Docking Simulation; Oviposition; Pyrimidines; Schistosoma mansoni; Schistosomatidae; Schistosomiasis; Schistosomiasis mansoni

2019